Optical Coherence Tomography in Retinal Vein Occlusion
Optical Coherence Tomography Data As a Prognostic Indicator in Retinal Vein Occlusion
1 other identifier
observational
30
0 countries
N/A
Brief Summary
This study aims to evaluate how optical coherence tomography (OCT) can help predict outcomes in patients with retinal vein occlusion (RVO), a condition that affects blood flow in the retina. RVO can cause macular edema, which is swelling in the part of the eye responsible for central vision. The study will use OCT scans to assess changes in the retina and how these changes relate to vision improvement over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2025
CompletedFirst Posted
Study publicly available on registry
March 20, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
ExpectedMarch 20, 2025
March 1, 2025
6 months
March 15, 2025
March 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
changes in OCT biomarkers and visual acuity post-treatment.
Correlation between baseline OCT biomarkers and visual acuity at presentation after 1, 3, and 6 months post-treatment.
6 months
Study Arms (1)
Adults with branch or central RVO, macular edema confirmed by OCT, and no prior RVO in the affected
Adults aged 18 years or older. Patients diagnosed with branch or central retinal vein occlusion. Patients with macular edema confirmed by OCT due to vein occlusion. Patients with no prior history of RVO in the affected eye.
Eligibility Criteria
patients with retinal vein occlusion (RVO), a condition that affects blood flow in the retina. RVO can cause macular edema, which is swelling in the part of the eye responsible for central vision. Adults aged 18 or older with branch or central retinal vein occlusion. Patients must have macular edema confirmed by OCT and no previous RVO in the affected eye.
You may qualify if:
- Adults aged 18 years or older.
- Patients diagnosed with branch or central retinal vein occlusion.
- Patients with macular edema confirmed by OCT due to vein occlusion.
- Patients with no prior history of RVO in the affected eye.
You may not qualify if:
- Presence of other retinal diseases that could affect OCT interpretation (e.g., diabetic retinopathy, age-related macular degeneration).
- History of intraocular surgery within the last three months.
- Presence of significant media opacities (e.g., dense cataract, vitreous hemorrhage) that interfere with OCT imaging.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident at the ophtalmology department
Study Record Dates
First Submitted
March 15, 2025
First Posted
March 20, 2025
Study Start
May 1, 2025
Primary Completion
October 30, 2025
Study Completion (Estimated)
December 30, 2026
Last Updated
March 20, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share